During the past decade, CHU de Nîmes - Hôpital Universitaire Carémeau conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Nîmes - Hôpital Universitaire Carémeau" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 21 trials, followed by "Nantes University Hospital" with 2 trials sponsored, "AM-Pharma" with 1 trials sponsored, "Coloplast A/S" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Nîmes - Hôpital Universitaire Carémeau" #1 collaborator was "DePuy Synthes" with 1 trials as a collaborator and "LDR Médical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Nîmes - Hôpital Universitaire Carémeau" are "Acute Kidney Injury Due to Sepsis" (1 trials), "Acute Renal Colic" (1 trials), "Administration of Antibiotics in Intensive Care Units" (1 trials), "Advanced Multiple Myeloma" (1 trials) and "Antiphospholipid Antibody Syndrome in Pregnancy" (1 trials). Many other conditions were trialed in "CHU de Nîmes - Hôpital Universitaire Carémeau" in a lesser frequency.

Most popular intervention types in "CHU de Nîmes - Hôpital Universitaire Carémeau" are "Other" (7 trials), "Biological" (6 trials), "Device" (5 trials), "Drug" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Blood sampling" (2 trials), "Placebo" (2 trials), "AlgiScan" (1 trials), "Bacteriological analysis of vaginal sample" (1 trials) and "Baseline activities" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Nîmes - Hôpital Universitaire Carémeau" are 18 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Nîmes - Hôpital Universitaire Carémeau". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in CHU de Nîmes - Hôpital Universitaire Carémeau, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Nîmes - Hôpital Universitaire Carémeau, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".